用化合物准Lin28/let-7轴来调节癌症中的转录控制
Xingpeng Wang1, Pham Kim Thuong Van2, Bo Liu2,3,4,5
1Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Anti-cancer agents in medicinal chemistry
|September 19, 2025
概括
林28蛋白抑制了let-7微RNA的成熟,通过上调瘤基因来促进癌症. 针对Lin28/let-7轴提供了一个治疗策略,抑制剂分为CSD/ZKD,非CSD/ZKD和let-7恢复剂.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 林28是一种RNA结合蛋白,对于let-7微RNA生物生成至关重要.
- 林28/let-7轴调节细胞增殖,分化和细胞亡.
- 林28/let-7的失调有助于瘤基因上调 (MYC,RAS,HMGA2),驱动癌症的开始,进展和转移.
研究的目的:
- 审查和分类针对癌症治疗的Lin28/let-7相互作用的抑制剂.
- 要总结最近在Lin28/let-7抑制剂开发方面的进展.
- 突出针对恶性瘤这一轴的治疗潜力.
主要方法:
- 综合文献综述. 这是一个全面的文献综述.
- 将Lin28/let-7抑制剂分为三个类别:CSD/ZKD抑制剂,非CSD/ZKD抑制剂和let-7恢复剂.
- 在每个类别内确定特定的抑制剂示例.
主要成果:
- CSD/ZKD 抑制剂 (例如TPEN,KCB3602) 结合 Lin28 域以抑制活性.
- 非CSD/ZKD抑制剂 (例如C1632,Simvastatin) 通过未知的机制降低Lin28活性.
- 通过调节相关因素,Let-7恢复器 (例如,IPA-3,FPA124) 间接恢复了let-7水平.
结论:
- 针对Lin28/let-7相互作用是癌症缺乏特定分子点的有希望的治疗策略.
- 已识别的抑制剂类别提供了各种方法来降低瘤基因表达的调节和抑制瘤进展.
- 这篇综述是对正在进行的针对癌症治疗的Lin28抑制剂的研究的宝贵参考.
关键词:
中心证券交易中心 (CSD) 是一个值得信赖的中心.在 ZKDD 中,你会看到癌症治疗 治疗 治疗 癌症让-7 让-7 让-7让-7 恢复恢复器在线2828 在线2828lin28 抑制剂的使用.小分子. 小分子.更多相关视频
相关概念视频
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Regulation of Expression at Multiple Steps
1.3K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K


